Insider trade

Director exercised or converted 31K GDRX derivative securities

Traded Jan 21, 2026 · Filed Jan 21, 2026

Goodrx HoldingsGDRX

31K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jan 21, 2026
Reporting period: Not applicable
Filed with the SEC: Jan 21, 2026

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001809519-26-000008

Filed / recorded

Jan 21, 2026, 10:20 PM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Scott Wagner

Relationship

Director

Security

Deferred Stock Unit

Table

Derivative (Table II)

Transaction date

Jan 21, 2026

Transaction code

M

Shares / units

31,394

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

62,788

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).